- Home
- FULC vs FINW Comparison
FULC vs FINW Comparison
Compare FULC & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- FINW
- Stock Information
- Founded
- FULC 2015
- FINW 1999
- Country
- FULC United States
- FINW United States
- Employees
- FULC N/A
- FINW N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- FULC Health Care
- FINW Finance
- Exchange
- FULC Nasdaq
- FINW Nasdaq
- Market Cap
- FULC 210.9M
- FINW 259.1M
- IPO Year
- FULC 2019
- FINW 2021
- Fundamental
- Price
- FULC $2.90
- FINW $17.63
- Analyst Decision
- FULC Hold
- FINW Buy
- Analyst Count
- FULC 8
- FINW 4
- Target Price
- FULC $6.57
- FINW $20.75
- AVG Volume (30 Days)
- FULC 427.3K
- FINW 25.8K
- Earning Date
- FULC 02-25-2025
- FINW 04-28-2025
- Dividend Yield
- FULC N/A
- FINW N/A
- EPS Growth
- FULC N/A
- FINW N/A
- EPS
- FULC N/A
- FINW 0.93
- Revenue
- FULC $80,000,000.00
- FINW $69,824,000.00
- Revenue This Year
- FULC N/A
- FINW $43.52
- Revenue Next Year
- FULC N/A
- FINW $21.91
- P/E Ratio
- FULC N/A
- FINW $18.83
- Revenue Growth
- FULC 2752.05
- FINW 9.10
- 52 Week Low
- FULC $2.78
- FINW $9.56
- 52 Week High
- FULC $11.85
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- FULC 29.80
- FINW 41.47
- Support Level
- FULC $2.82
- FINW $18.48
- Resistance Level
- FULC $3.09
- FINW $18.04
- Average True Range (ATR)
- FULC 0.30
- FINW 0.71
- MACD
- FULC -0.04
- FINW -0.30
- Stochastic Oscillator
- FULC 10.86
- FINW 27.54
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.